RISS Versus SPSIP Block in Modified Radical Mastectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorFerit Yetik
About this trial
This prospective randomized double-blind controlled trial aims to compare the postoperative analgesic efficacy and dermatomal spread of rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block in patients undergoing modified radical mastectomy. Postoperative pain scores, opioid consumption, rescue analgesic requirements, block-related complications, and quality of recovery outcomes will be evaluated.
Eligibility criteria
Qualifiers
Female patients aged 18-75 years
ASA physical status I-III
Scheduled for elective unilateral modified radical mastectomy with axillary dissection under general anesthesia
Provision of written informed consent
Disqualifiers
Anticoagulant therapy
Bleeding diathesis
Known allergy to local anesthetics or opioids
Infection at the block application site or previous surgery in the block area
Trial design
Treatments tested in this trial
- Rhomboid Intercostal-Subserratus Plane Block
- Serratus Posterior Superior Intercostal Plane Block
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Ferit Yetik
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Sponsor institution
Bursa City Hospital
Collaborator
Source ClinicalTrials.gov